Get the Stockscreener App
0.0415
3.94%
-0.0017
Ocean Biomedical Inc stock is traded at $0.0415, with a volume of 8.41M.
It is down -3.94% in the last 24 hours and down -33.06% over the past month.
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.
See More
Previous Close:
$0.0432
Open:
$0.0418
24h Volume:
8.41M
Relative Volume:
0.17
Market Cap:
$7.74M
Revenue:
-
Net Income/Loss:
$-82.19M
P/E Ratio:
-0.0134
EPS:
-3.0969
Net Cash Flow:
$-8.35M
1W Performance:
-5.25%
1M Performance:
-33.06%
6M Performance:
-95.89%
1Y Performance:
-97.68%
1-Day Range:
$0.037
$0.042
1-Week Range:
$0.037
$0.048
52-Week Range:
$0.037
$2.09
Ocean Biomedical Inc Stock (OCEA) Company Profile
Name
Ocean Biomedical Inc
Sector
Industry
Phone
(646) 908-2658
Address
515 MADISON AVE SUITE 8078, NEW YORK
Compare OCEA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCEA
Ocean Biomedical Inc
|
0.0415 | 7.74M | 0 | -82.19M | -8.35M | -3.0969 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Ocean Biomedical Inc Stock (OCEA) Latest News
Ocean Biomedical Delays Yearly Report Filing - MSN
Ocean Biomedical stock plunges to 52-week low of $0.04 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.04 By Investing.com - Investing.com Canada
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decrease in Short Interest - Defense World
Troubled Brown spinoff Ocean Biomedical racked up more losses in 2024 - The Business Journals
SEC filing of the week: Ocean Biomedical’s loss narrows to $9.4M in 2024 - Providence Business News
Ocean Biomedical, Inc. SEC 10-K Report - TradingView
Ocean Biomedical stock plunges to 52-week low of $0.05 - Investing.com
Ocean Biomedical stock plunges to 52-week low of $0.05 By Investing.com - Investing.com South Africa
Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Large Decline in Short Interest - Defense World
New CEO, several board members to step down from Ocean Biomedical - Providence Business News
Ocean Biomedical secures key patent in China for cancer therapy By Investing.com - Investing.com South Africa
Ocean Biomedical secures key patent in China for cancer therapy - Investing.com
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China - The Manila Times
Ocean Biomedical Announces Grant on Patent Right - GlobeNewswire
Revolutionary Cancer Treatment Patent Secured: Dual-Target Antibody Breaks Ground in Chinese Market - Stock Titan
Four board members to exit troubled RI biotechProvidence Business First - The Business Journals
Ocean Biomedical slashes conversion price on investor note By Investing.com - Investing.com Australia
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Ocean Biomedical stock plunges to 52-week low of $0.07 By Investing.com - Investing.com Australia
Ocean Biomedical stock plunges to 52-week low of $0.07 - Investing.com
Ocean Biomedical announces board reshuffle amid resignations By Investing.com - Investing.com Australia
Ocean Biomedical announces board reshuffle amid resignations - Investing.com
Ocean Biomedical issues Series A preferred stock - Investing.com India
Ocean Biomedical issues Series A preferred stock By Investing.com - Investing.com South Africa
Ocean Biomedical stock plunges to 52-week low of $0.11 By Investing.com - Investing.com Canada
Ocean Biomedical amends shareholder meeting quorum By Investing.com - Investing.com Australia
Ocean Biomedical amends shareholder meeting quorum - Investing.com
Ocean Biomedical Inc’s (OCEA) 10.77% Increase Justifies A Second Look - Stocks Register
Ocean Biomedical stock plunges to 52-week low of $0.46 - MSN
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Ocean Biomedical reports unregistered equity sales - Investing.com India
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Biodexa stock soars 76% on FDA Fast Track status for eRapa - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Best Penny Stocks for Today (Charts Updated Daily) - Benzinga
Dow Falls 100 Points; Coca-Cola Posts Upbeat Earnings - Benzinga India
Ocean Biomedical Inc (OCEA) can make a big difference with a little luck - SETE News
IRIS Bio selects Koehler Paper for flexible pasta packaging - Yahoo
A Look at TripAdvisor Inc (TRIP) Shares in the Recent Past Indicates Growth - SETE News
Prepare Yourself for Liftoff: Conmed Corp (CNMD) - SETE News
ZIWIG ENDOTEST®: FAST-TRACK REIMBURSEMENT FOR 25 000 PATIENTS FOR FIRST SALIVA TEST TO DIAGNOSE ENDOMETRIOSIS IN 80 MEDICAL CENTERS IN FRANCE - Yahoo Finance
US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget - Yahoo Finance
Ocean Biomedical Inc Stock (OCEA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):